logo-loader
LSE:RENE FRA:RQE1

ReNeuron Group PLC

Receive alerts
Market:
LSE
Market Cap:
£45.04 m
Price
141.50 GBX
Change
-1.74%
52 weeks high
297.50
52 weeks low
71.00

In brief

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

Deep dive We explore the investor case for growth companies

Snapshot

  • Developer of stem cell technologies
  • Has two clinical stage technologies
  • Stroke treatment in Phase IIb trials